Skip to main content
padlock icon - secure page this page is secure

Non-peptide Opioid Receptor Ligands - Recent Advances. Part I - Agonists

Buy Article:

$68.00 + tax (Refund Policy)

Developments in the domain of non-peptide opioid receptor agonists, beginning from the first evidence of opiate binding to definite receptors, are briefly summarized. The recent achievements are in a more detailed way depicted and discussed. Novel agonists for each of three opioid receptor basic types (δ DOR), κ (KOR) and μ MOR)) are presented with the special emphasis on one-type-selective ligands. Such selective or even specific agonists have been synthesized with a moderate success. Considerably more serious difficulties concern searching for selective ligands for opioid receptor subtypes (μ1(MOR1), (μ2 (MOR2), δ1 (DOR1), δ2 (DOR2), κ1 (KOR1), κ2 (KOR2), κ3 (KOR3)) which may be connected with the fact that dissimiliarities observed in vivo result from postbinding processes (signaling).

For the large number of opioid receptor ligands, their structural diversity and relative easiness of generating them from combinatorial libraries (not comparable even with that of orphanine receptors) it is justified to consider the plasticity of opioid receptors (MOR especially). This remark, in conjunction with the existence of opioid receptor types and subtypes, may enable to create new drugs with significantly reduced sideeffects.

The above facts and brand new reports about highly-active opioid agonists possessing no moieties thought to be essential for agonist activity make the need of reevaluation of classical opioid receptor pharmacophore model extremely important.

In general, research results suggest that selective agonists of opioid receptors can be found both in morphine type of ligands and new structures like pyrido-acridine derivatives (COMP1) or diphenylmethylpiperazine derivatives (SNC 80). Better understanding of the structural prerequisites of the opioid receptors binding domains will certainly lead to even more potent and more selective ligands in near future.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: binding domain; non-peptide agonists; opioid receptors; pharmacophore models

Document Type: Review Article

Affiliations: Department of Synthesis and Technology of Drugs, Faculty of Pharmacy, Medical University at Lublin, 6 Staszica Str., PL-20081 Lublin, Poland.

Publication date: January 1, 2004

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more